Osmotica Pharmaceuticals plc announced the appointment of Michael J. DeBiasi to the Company’s Board of Directors, effective as of October 1, 2019. Since December 2018, Mr. DeBiasi has held the position of CEO – Kramer Consumer Healthcare. From October 2014 to November 2018, Mr. DeBiasi held positions of increasing responsibility at Bayer US, where he was Vice President and General Manager – US Nutritionals and Digestive Health.